Evolution of P-wave indices during long-term follow-up as markers of atrial substrate progression in arrhythmogenic right ventricular cardiomyopathyShow others and affiliations
2021 (English)In: Europace, ISSN 1099-5129, E-ISSN 1532-2092, Vol. 23, no Supplement_1, p. i29-i37Article in journal (Refereed) Published
Abstract [en]
AIMS: Patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) have increased prevalence of atrial arrhythmias indicating atrial involvement in the disease. We aimed to assess the long-term evolution of P-wave indices as electrocardiographic (ECG) markers of atrial substrate during ARVC progression.
METHODS AND RESULTS: We included 100 patients with a definite ARVC diagnosis according to 2010 Task Force criteria [34% females, median age 41 (inter-quartile range 30-55) years]. All available sinus rhythm ECGs (n = 1504) were extracted from the regional electronic ECG databases and automatically processed using Glasgow algorithm. P-wave duration, P-wave area, P-wave frontal axis, and prevalence of abnormal P terminal force in lead V1 (aPTF-V1) were assessed and compared at ARVC diagnosis, 10 years before and up to 15 years after diagnosis.Prior to ARVC diagnosis, none of the P-wave indices differed significantly from the data at ARVC diagnosis. After ascertainment of ARVC diagnosis, P-wave area in lead V1 decreased from -1 to -30 µV ms at 5 years (P = 0.002). P-wave area in lead V2 decreased from 82 µV ms at ARVC diagnosis to 42 µV ms 10 years after ARVC diagnosis (P = 0.006). The prevalence of aPTF-V1 increased from 5% at ARVC diagnosis to 18% by the 15th year of follow-up (P = 0.004). P-wave duration and frontal axis did not change during disease progression.
CONCLUSION: Initial ARVC progression was associated with P-wave flattening in right precordial leads and in later disease stages an increased prevalence of aPTF-V1 was seen.
Place, publisher, year, edition, pages
Oxford University Press, 2021. Vol. 23, no Supplement_1, p. i29-i37
Keywords [en]
Arrhythmogenic cardiomyopathy, Atrial fibrillation, P-terminal force in lead V1, P-wave area in lead V1, P-wave area in lead V2
National Category
Cardiac and Cardiovascular Systems
Identifiers
URN: urn:nbn:se:liu:diva-175169DOI: 10.1093/europace/euaa388ISI: 000637048300013PubMedID: 33751075Scopus ID: 2-s2.0-85103433165OAI: oai:DiVA.org:liu-175169DiVA, id: diva2:1546458
Note
Funding: Swedish Heart-Lung FoundationSwedish Heart-Lung Foundation; Skane University Hospital (Lund, Sweden); Swedish healthcare system (ALF); The Swedish Institute; Theo-Rossi di Montelera (TRM) foundation
2021-04-222021-04-222021-05-10Bibliographically approved